Hevobet Cream contains Halobetasol 0.05% w/w, a potent topical corticosteroid indicated for the treatment of various inflammatory and pruritic dermatoses, including psoriasis, eczema, and dermatitis. Halobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses in the skin. Hevobet Cream is formulated for topical application and should be applied sparingly to the affected areas once or twice daily as directed by a healthcare professional. The duration of therapy is generally limited to avoid potential adverse effects associated with prolonged corticosteroid use, such as skin atrophy, striae, and systemic absorption leading to hypothalamic-pituitary-adrenal axis suppression. It is contraindicated in patients with hypersensitivity to halobetasol or any component of the formulation, as well as in untreated cutaneous infections, including bacterial, viral, or fungal infections. Caution is advised when applying to large surface areas, broken or damaged skin, or in pediatric populations. Patients should be advised to avoid occlusive dressings unless prescribed and to discontinue use if irritation or sensitization occurs. Hevobet Cream should be stored at room temperature, away from direct sunlight and moisture. Consultation with a healthcare provider is essential prior to initiation to ensure appropriate use and monitoring.